Engrail is a startup based in the United States, 3 tracked investors.
Engrail is a company founded in 2019 headquartered in the United States. Brouky records 3 investors associated with the company.
Engrail is a clinical-stage pharmaceutical company developing precision-targeted therapies for neurological and neuropsychiatric disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.